Corrigendum: LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.862010
Abstract: [This corrects the article DOI: 10.3389/fmed.2021.795427.]. read more here.
Keywords: biomarker predicts; msc as1; corrigendum lncrna; diagnostic biomarker ... See more keywords